Investigators assessed the link between antibiotic consumption and resistance and H pylori infections in European countries.
Researchers performed a network meta-analysis to compare the effectiveness of first-line regimens vs standard triple therapy in the treatment of H pylori infection.
Researchers compared the efficacy, adverse events, and compliance of HDDT vs BQT as first-line or rescue regimens and investigated factors contributing to H pylori eradication.
Researchers aimed to evaluate outcomes of H pylori treatment and identify any risk factors for failure in patients with HIV.
Vonoprazan is an oral small molecule potassium-competitive acid blocker.
Researchers investigated the effects of H pylori on the clinical presentation and disease course of COVID-19 infections.
Investigators sought to explore the past temporal trends (1988-2012) in gastric cancer incidence rates in 43 countries and to predict future trends (2012-2030).
Investigators tested the accuracy of the EndoFaster® device in performing gastric juice analysis, with the goal of reducing the need for gastric biopsies in the detection of H pylori.
Researchers compared the efficacy of 10-Day Bismuth Quadruple Therapy vs 7-day Clarithromycin Triple Therapy.
Researchers assessed the correlation between Helicobacter pylori infection and biological characteristics of early gastric cancer.
Researchers assessed the effects of different H pylori infections on distribution of histopathological characteristics and items of serum gastric function.
Investigators evaluated the relationship among Helicobacter pylori infection, atrophic gastritis, and chronic kidney disease.
A team of investigators conducted a multicenter, randomized, controlled trial to identify factors related to the eradication of H pylori with dual vonoprazan and amoxicillin as first-line therapy.
A team of investigators sought to determine factors that affect the success of second-line therapy using vonoprazan, a gastric acid secretion inhibitor that improves the success rate of Helicobacter pylori eradication.
The American Gastroenterological Association issued a clinical practice update to provide clinicians with practical advice on how to manage patients for whom initial treatment for H pylori infection was unsuccessful.
Investigators performed a cross-sectional study to assess reflux esophagitis in patients having undergone successful eradication of Helicobacter pylori infection.
Study finds that only 2% of duodenal biopsies demonstrated H pylori; therefore, routine examination of chronic peptic duodenitis may be unnecessary.
A team of investigators conducted a prospective, multicenter study to assess the safety of H pylori eradication therapy in adolescent students.
A team of investigators conducted a large retrospective, cohort study to assess whether a longitudinal link exists between H pylori infection and the risk of developing dyslipidemia.
A team of investigators explored the ability of different machine learning models to predict the risk of gastric cancer development in patients who had undergone eradication of Helicobacter pylori infection.